Article
Enhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.
BMC cancer - 25 Sept 2014
Tan Fang, Mosunjac Marina, Adams Amy L, Adade Beverly, Taye Oleyad, Hu Yijuan, Rizzo Monica, Ofori-Acquah Solomon F
Abstract excerpt
BACKGROUND: Variation in tumor biology in African-American (AA) and Caucasian (CAU) women with breast cancer is poorly defined. Activated leukocyte cell adhesion molecule (ALCAM) is a bad prognostic factor of breast cancer yet it has never being studied in the AA population. We tested the hypothesis that ALCAM expression would be markedly lower in cases of AA breast cancer when compared to CAU. METHODS: Cases of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
